Get started
Author

Naoki Sekine

Observed names: N Sekine, Naoki SEKINE
ORCID: 0000-0001-5435-5462
Observed ORCID: 0000-0001-5435-5462
OpenAlex ID: A5078480640
Inhibition of Akt/mTOR pathway overcomes intrinsic resistance to dasatinib in triple-negative breast cancer
2020 · Yuya Haga, Kazuma Higashisaka, et al. · Biochemical and Biophysical Research Communications · 16
PDF
Alpha-crystallin B chains in trastuzumab-resistant breast cancer cells promote endothelial cell tube formation through activating mTOR
2021 · Lili Yang, Kazuma Higashisaka, et al. · Biochemical and Biophysical Research Communications · 6
PDF
Early-onset, treatment-cycle-linked hyperinsulinaemic insulin resistance during capivasertib therapy: a case report
2026 · Yosuke Motai, Shotaro Nakamura, et al. · Cardiovascular Diabetology – Endocrinology Reports · 1
PDF
Coexisting mild autonomous cortisol secretion and isolated adrenocorticotropic hormone deficiency in a patient with an adrenal incidentaloma
2026 · Koki Ikeda, Shotaro Nakamura, et al. · JCEM Case Reports · 1
Urinary Liver‐Type Fatty Acid‐Binding Protein, Albuminuria, and eGFR Trajectories in Type 2 Diabetes
2026 · Hiroaki Satoh, Shotaro Nakamura, et al. · Journal of Diabetes
PDF
Pheochromocytoma unmasked by rapid deterioration of previously stable type 2 diabetes
2026 · Nozomi Sasatsuki, Shotaro Nakamura, et al. · JCEM Case Reports
Abstract B035: The role of αB-crystallin in chemotherapy-induced migration of triple negative breast cancer
2019 · Lili YANG, Kazuma HIGASHISAKA, et al. · Molecular Cancer Therapeutics
Abstract A04: Dasatinib shows different cytotoxicity in triple-negative breast cancer cell lines
2018 · Yuya Haga, Kazuma Higashisaka, et al. · Molecular Cancer Research
[A case of cutaneous malignant melanoma metastatic to the choroid].
1995 · H Suzuki, J Suzuki, et al. · PubMed
Works count: 9
Citation count: 24
H-index: 2
I10-index: 1
Year
Topic
Type